Browsing by Author Donnan, Geoffrey

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 16 of 16
Issue DateTitleAuthor(s)Citation
2014Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trialsLindley, Richard; Albers, Gregory; Blackwell, Lisa; Bluhmki, Erich; Brott, Thomas; Cohen, Geoff; Davis, Stephen; Donnan, Geoffrey; Emberson, Jonathan; et al, Various; Lees, Kennedy R; Lyden, Patrick; Western Clinical School: Medicine (Westmead)Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials, The Lancet, vol.384, 9958, 2014,pp 1929-1935
2003Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS TrialAnderson, Craig; Chalmers, John; Chapman, Neil; Coleman, Samuel; Huxley, Rachel; MacMahon, Stephen; Neal, Bruce; Woodward, Mark; Bousser, M-G; Davis, Stephen; Donnan, Geoffrey; Warlow, C.; The George Institute for International Health; The George Institute for International Health; Medicine; School of Public Health: NH&MRC Clinical Trials Centre; The George Institute for International Health; The George Institute for International Health; The George Institute for International Health; The George Institute for International HealthEffects of a Perindopril-Based Blood Pressure–Lowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History: The PROGRESS Trial, Stroke: a journal of cerebral circulation, vol.35,(1),2003,pp 116-121
2009Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)Chalmers, John; Neal, Bruce; Woodward, Mark; Anderson, Neil; Bladin, Chris; Chambers, Brian; Donnan, Geoffrey; Gordon, Garry; Ninomiya, Toshiharu; Sharpe, Norman; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global HealthEffects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS), Stroke: a journal of cerebral circulation, vol.40, 6, 2009,pp 2111-2115
2015Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trialLindley, Richard; Bernhardt, Julie; Churilov, Leonid; Collier, Janice M; Dewey, Helen M; Donnan, Geoffrey; Ellery, Fiona; Langhorne, Peter; Moodie, Marjory; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial, The Lancet, vol.386, 9988, 2015,pp 46-55
2015Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trialLindley, Richard; Bernhardt, Julie; Churilov, Leonid; Collier, Janice M; Dewey, Helen M; Donnan, Geoffrey; Ellery, Fiona; Langhorne, Peter; Moodie, Marjory; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial, The Lancet, vol.386, 9988, 2015,pp 46-55
2015Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trialLindley, Richard; Bernhardt, Julie; Churilov, Leonid; Collier, Janice M; Dewey, Helen M; Donnan, Geoffrey; Ellery, Fiona; Langhorne, Peter; Moodie, Marjory; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial, The Lancet, vol.386, 9988, 2015,pp 46-55
2015Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trialLindley, Richard; Bernhardt, Julie; Churilov, Leonid; Collier, Janice M; Dewey, Helen M; Donnan, Geoffrey; Ellery, Fiona; Langhorne, Peter; Moodie, Marjory; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial, The Lancet, vol.386, 9988, 2015,pp 46-55
2003International Society of hypertension (ISH): Statement on blood pressure lowering and stroke preventionChalmers, John; Chapman, Neil; Frommer, Michael; Huxley, Rachel; MacMahon, Stephen; Todd, Angela; Beilin, Lawrie; Davis, Stephen; Donnan, Geoffrey; Lenfant, Claude; Mancia, Giuseppe; Mendis, Shanthi; Whitworth, Judith A; Zanchetti, Alberto; The George Institute for International Health; Education Faculty Admin; School of Public Health: Public Health; The George Institute for International Health; The George Institute for International Health; MedicineInternational Society of hypertension (ISH): Statement on blood pressure lowering and stroke prevention, Journal of Hypertension, vol.21,(4),2003,pp 651-663
2017Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)Lindley, Richard; Arima, Hisatomi; Bath, Philip; Billot, Laurent; Broderick, Joseph; Demchuk, Andrew; Donnan, Geoffrey; et al, Various; Kim, Jong S.; Robinson, Thompson G.; Wang, Xia; Westmead Clinical School: MedicineLow- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study), Stroke, vol.48, 7, 2017,pp 1887-1883
2017Low-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trialAnderson, Craig; Chalmers, John; Lindley, Richard; Wang, Xia; Woodward, Mark; Arima, Hisatomi; Bath, Philip; Billot, Laurent; Broderick, Joseph; Demchuk, Andrew; Donnan, Geoffrey; et al, Various; Lee, Tsong-Hai; Li, Q; Robinson, Thompson G.; School of Public Health: Public Health; The George Institute for Global Health; Western Clinical School: Medicine (Westmead); Northern Clinical School: Medicine; The George Institute for Global HealthLow-dose vs standard-dose alteplase for patients with acute ischemic stroke: Secondary analysis of the ENCHANTED randomized clinical trial, JAMA Neurology, vol.74, 11, 2017,pp 1328-1335
2013Pathophysiology of spasticity in strokeBurke, David; Donnan, Geoffrey; Wissel, Jorg; Central Clinical School: MedicinePathophysiology of spasticity in stroke, Neurology, vol.80, 3 Suppl 2, 2013,pp S20-S26
2016Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)Lindley, Richard; Bernhardt, Julie; Chamberlain, Jan; Churilov, Leonid; Collier, Janice M; Dewey, Helen M; Donnan, Geoffrey; Ellery, Fiona; Langhorne, Peter; Moodie, Marj; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT), Neurology, vol.86, 23, 2016,pp 2138-2145
2015Readmissions after stroke: linked data from the Australian Stroke Clinical Registry and hospital databasesAnderson, Craig; Lannin, Natasha Anne; Andrew, Nadine E; Cadilhac, Dominique A; Dewey, Helen M; Donnan, Geoffrey; Kilkenny, Monique F; Sundararajan, Vijaya; The George Institute for Global Health; Northern Clinical School: MedicineReadmissions after stroke: linked data from the Australian Stroke Clinical Registry and hospital databases, Medical Journal of Australia, vol.203, 2, 2015,pp 102-106
2014The Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): Protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trialAnderson, Craig; Delcourt, Candice; Aviv, Richard I; Barras, Christine; Bladin, Christopher F; Campbell, Bruce; Churilov, Leonid; Davis, Stephen; Donnan, Geoffrey; Jannes, Jim; Kleinig, Timothy; Lee, Andrew W.; Levi, Christopher; Mahant, Neil; Markus, Romesh; Meretoja, Atte; Mitchell, Peter; Nandurkar, Harshal; Parsons, Mark W; Rupasinghe, Jayantha; Spratt, Neil; Sturm, Jonathan; Wijeratne, Tissa; Yan, Bernard; Yassi, Nawaf; Zavala, Jorge; The George Institute for Global Health; The George Institute for Global HealthThe Spot sign and Tranexamic acid On Preventing ICH growth - AUStralasia Trial (STOP-AUST): Protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial, International Journal of Stroke, vol.9, 4, 2014,pp 519-524
2015Statistical analysis plan (SAP) for A Very Early Rehabilitation Trial (AVERT): an international trial to determine the efficacy and safety of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset vs. usual stroke unit careLindley, Richard; Bernhardt, Julie; Churilov, Leonid; Collier, Janice; Dewey, Helen; Donnan, Geoffrey; Langhorne, Peter; Moodie, Marj; Thrift, Amanda G.; Western Clinical School: Medicine (Westmead)Statistical analysis plan (SAP) for A Very Early Rehabilitation Trial (AVERT): an international trial to determine the efficacy and safety of commencing out of bed standing and walking training (very early mobilization) within 24 h of stroke onset vs. usual stroke unit care, International Journal of Stroke, vol.10, 1, 2015,pp 23-24
2013Telephone follow-up was more expensive but more efficient than postal in a national stroke registryAnderson, Craig; Lannin Marshman, Natasha; Lim, Joyce; Cadilhac, Dominique; Donnan, Geoffrey; Faux, Steven; Levi, Christopher; Paice, Kate; Price, Chris; The George Institute for Global Health; Northern Clinical School: Medicine; The George Institute for Global HealthTelephone follow-up was more expensive but more efficient than postal in a national stroke registry, Journal of Clinical Epidemiology, vol.66, 8, 2013,pp 896-902